TheFly reported on June 25 that NRXP issued a statement responding to claims made by Kadima Neuropsychiatry Institute ...
NRX Pharmaceuticals NRXP shares are trading sharply lower in after-hours trading on Tuesday. NRXP shares fell 19.05% to $3.74 in after-hours trading after the company announced a proposed underwritten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results